Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 16.98
+0.04 (0.24%)
Apr 2, 2026, 4:08 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 18.02 billion as of April 2, 2026. Its market cap has increased by 140.11% in one year.
Market Cap
18.02B
Enterprise Value
15.91B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.98
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has increased from 15.69B to 18.02B, an increase of 14.84%. That is a compound annual growth rate of 1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 18.02B | 60.29% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 28.95B |
| TransThera Sciences (Nanjing) | 27.63B |
| Genscript Biotech | 25.91B |
| Keymed Biosciences | 19.74B |
| Ascentage Pharma Group International | 19.14B |
| Zai Lab | 17.96B |
| Nanjing Leads Biolabs | 17.39B |
| Everest Medicines | 14.26B |